shortagewatch

Home / Blood / Coagulation Factor VIII

ATC B02BD02 · Antihemorrhagics

Coagulation Factor VIII shortage

As of 31 Oct 2026, Coagulation Factor VIII has a reported shortage in 4 of the 5 countries we track (Italy, Spain, Austria, Belgium), covering 5 products.

Countries4/5
Products5packs or presentations
Short since16 Feb 20268 months ago
Earliest return1 Nov 2026company estimate
No return date2products
Main reasonManufacturing problem

Timeline

ItalySpainAustriaBelgium
2027HAEMOCTINHAEMOCTINJIVI 3000 UI POLVO Y DISOLVENTE PARA SOLUCIOJIVI 3000 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE, 1 vial + 1 jeringa precargadaHaemoctin SDH 500 Pulver und Lösungsmittel zHaemoctin SDH 500 Pulver und Lösungsmittel zur Herstellung einer Injektionslösung, 1 StückReFacto AF 250 IU inj. sol. (pwdr. + solv.) ReFacto AF 250 IU inj. sol. (pwdr. + solv.) i.v. pre-filled syr. 250 IU + 4 mlJivi 1 000 IU inj. sol. (pwdr. + solv.) i.v.Jivi 1 000 IU inj. sol. (pwdr. + solv.) i.v. vial + pre-filled syr. 1000 IU + 2.5 mltoday

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

Affected products

CountryProductHolderSinceExpected backReason
ITHAEMOCTINBIOTEST PHARMA GMBH16 Feb 2026not givenManufacturing problem
Problemi produttivi
ESJIVI 3000 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE, 1 vial + 1 jeringa precargadaBayer Ag14 Oct 202614 Dec 2026Not stated
ATHaemoctin SDH 500 Pulver und Lösungsmittel zur Herstellung einer Injektionslösung, 1 StückBiotest Pharma GmbH2 Jun 20261 Nov 2026Manufacturing problem
Kapazitätsengpässe bei der Herstellung
BEReFacto AF 250 IU inj. sol. (pwdr. + solv.) i.v. pre-filled syr. 250 IU + 4 mlPfizer Europe MA7 Apr 202631 Dec 2026Other
Other reason
BEJivi 1 000 IU inj. sol. (pwdr. + solv.) i.v. vial + pre-filled syr. 1000 IU + 2.5 mlBayer27 Jul 2026not givenIncreased demand

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.

Related medicines also in short supply